Manufacturing roundup: Lonza finishes expanding Visp site; CBM to produce jCyte’s cell therapy
Lonza has opened the doors to an expansion at one of its primary locations.
The expansion occurred at Lonza’s highly potent API (HPAPIs) suite at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
